Mauna Kea Technologies SA (0P5I.L)
LSE · EUR
€0.0959 (-11.69%) as of
Key statistics
- EPS (TTM)
- -0.3530
- 52-week range
- 0.0951 – 0.7630
- Beta
- 0.94
- Revenue (TTM)
- 8.38M
- Profit margin
- 126.86%
- Volume
- 659.00
About Mauna Kea Technologies SA
Mauna Kea Technologies SA manufactures and sells medical devices in Europe, Middle East, Africa, the United States, Canada, and Asia. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables physicians to monitor disease progression over time, assess reactions as they occur, classify areas of uncertainty, and guide surgical procedures, and help diagnose and treat patients. The company was incorporated in 2000 and is headquartered in Paris, France.
- Headquarters
- Paris, France
- Employees
- 56
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.